freemexy's blog
A suspect has been arrested in connection to four separate lottery
ticket burglaries in Surprise, according to the Surprise Police
Department. Get more news about 菲律宾彩票包网公司,you can vist loto98.com
The suspect, 31-year-old Chad Robert Essman, was taken into custody by the El Mirage Police Department, authorities said. An officer detained Essman after he watched the suspect turn in multiple lottery tickets and matched his description to an identity flyer given to police departments. The first instance of the string of lottery ticket thefts took place at a Chevron on Jan. 25, police said. A witness chased the burglar attempting to get the tickets back. After knocking one of the ticket display cases out, the witness was threatened by the burglar with a black firearm before the burglar fled.
Three other burglaries took place throughout February in Surprise, all involving a similar-looking man, authorities said. The thefts happened at Circle Ks around the same general area, all of which had security footage that was given to authorities. Police were also notified that one of the stolen tickets was being redeemed at a QuickTrip, 30 minutes after one of the thefts happened, police said. After being arrested, Essman was confirmed by authorities to be the individual in the security footage from the stores that were robbed, police said. The suspect was also carrying all of the shirts with him in a garbage bag upon arrest and was identified by the witness of the first burglary in a photo lineup. Essman was charged with armed robbery with a deadly weapon and burglary in the third degree.
The suspect, 31-year-old Chad Robert Essman, was taken into custody by the El Mirage Police Department, authorities said. An officer detained Essman after he watched the suspect turn in multiple lottery tickets and matched his description to an identity flyer given to police departments. The first instance of the string of lottery ticket thefts took place at a Chevron on Jan. 25, police said. A witness chased the burglar attempting to get the tickets back. After knocking one of the ticket display cases out, the witness was threatened by the burglar with a black firearm before the burglar fled.
Three other burglaries took place throughout February in Surprise, all involving a similar-looking man, authorities said. The thefts happened at Circle Ks around the same general area, all of which had security footage that was given to authorities. Police were also notified that one of the stolen tickets was being redeemed at a QuickTrip, 30 minutes after one of the thefts happened, police said. After being arrested, Essman was confirmed by authorities to be the individual in the security footage from the stores that were robbed, police said. The suspect was also carrying all of the shirts with him in a garbage bag upon arrest and was identified by the witness of the first burglary in a photo lineup. Essman was charged with armed robbery with a deadly weapon and burglary in the third degree.
China Proposes Postponement of Its 'Two Sessions' in March China has
proposed postponing its annual "Two Sessions" meetings in March of the
national legislature and top political advisory body pending a final
decision next Monday, according to state media Xinhua News.To get more
news about China Two Sessions, you can visit shine news official website.
Observers say the call, once finalized, will highlight the Chinese government's priority in fighting the coronavirus (COVID-19) outbreak.Deliberations of the nation's major policy issues, including its annual military budget and future economic outlook, will also be delayed. Challenging year ahead The delays suggest a challenging year ahead politically and economically for China's top leadership, analysts say. "Now is a critical moment for China to fight the epidemic and stop the spread of the virus. (We) have to stay focused and make all-out efforts," Zang Tiewei, a spokesperson for China's National People's Congress (NPC), told Xinhua News after the close of an NPC standing committee meeting.Zang added that NPC delegates in one-third of Chinese provinces are playing a leading role on the front line fighting the deadly virus. Thus, it is necessary to consider postponing March's meetings — a proposal to be discussed later this month, he added.
Jean-Pierre Cabestan, a political science professor at Hong Kong Baptist University, agreed, saying it is only practical for China to push back the meetings, as disrupted transportation will make it difficult for delegates from across the country to travel to Beijing. Cabestan said it is too dangerous to gather some 5,000 members of the nation's political elites without exposing them to the risk of cross-infection. The postponement, he said, will also send a message. "What it says is that there's a clear priority given by the leadership to fight against the virus and epidemic. It transcends everything, including Two Sessions, but also putting the economy in place and resuming economic activities," he told VOA. Cabestan said Chinese authorities are now doubling down on restrictive measures to contain the health crisis, although there remains public discontent with the way Chinese governments at all levels managed the outbreak and how they still fail to effectively contain it.
Dissidents who refuse to be silent about the outbreak risk being jailed.The fact that Chinese President Xi Jinping still manages to install some of his protégés to handle the crisis in Hubei province shows that his authority isn't weakened, according to Cabestan. On Thursday, Ying Yong, the former mayor of Shanghai, was appointed to replace Hubei Party secretary Jiang Chaoliang. Wang Zhonglin, former party secretary of Jinan in Shangdong province, replaced Ma Guoqiang, the party leader of Wuhan. Wuhan, the capital of Hubei, is where the virus first surfaced.Jiang and Ma were fired because of their botched responses to the outbreak, although the two had previously said it wasn't within their power to disclose the outbreak.
Observers say the call, once finalized, will highlight the Chinese government's priority in fighting the coronavirus (COVID-19) outbreak.Deliberations of the nation's major policy issues, including its annual military budget and future economic outlook, will also be delayed. Challenging year ahead The delays suggest a challenging year ahead politically and economically for China's top leadership, analysts say. "Now is a critical moment for China to fight the epidemic and stop the spread of the virus. (We) have to stay focused and make all-out efforts," Zang Tiewei, a spokesperson for China's National People's Congress (NPC), told Xinhua News after the close of an NPC standing committee meeting.Zang added that NPC delegates in one-third of Chinese provinces are playing a leading role on the front line fighting the deadly virus. Thus, it is necessary to consider postponing March's meetings — a proposal to be discussed later this month, he added.
Jean-Pierre Cabestan, a political science professor at Hong Kong Baptist University, agreed, saying it is only practical for China to push back the meetings, as disrupted transportation will make it difficult for delegates from across the country to travel to Beijing. Cabestan said it is too dangerous to gather some 5,000 members of the nation's political elites without exposing them to the risk of cross-infection. The postponement, he said, will also send a message. "What it says is that there's a clear priority given by the leadership to fight against the virus and epidemic. It transcends everything, including Two Sessions, but also putting the economy in place and resuming economic activities," he told VOA. Cabestan said Chinese authorities are now doubling down on restrictive measures to contain the health crisis, although there remains public discontent with the way Chinese governments at all levels managed the outbreak and how they still fail to effectively contain it.
Dissidents who refuse to be silent about the outbreak risk being jailed.The fact that Chinese President Xi Jinping still manages to install some of his protégés to handle the crisis in Hubei province shows that his authority isn't weakened, according to Cabestan. On Thursday, Ying Yong, the former mayor of Shanghai, was appointed to replace Hubei Party secretary Jiang Chaoliang. Wang Zhonglin, former party secretary of Jinan in Shangdong province, replaced Ma Guoqiang, the party leader of Wuhan. Wuhan, the capital of Hubei, is where the virus first surfaced.Jiang and Ma were fired because of their botched responses to the outbreak, although the two had previously said it wasn't within their power to disclose the outbreak.
Foreign Investment a Focal Point for China’s 2020 Two Sessions
Congressional Event Maintaining and shoring up foreign investment
levels has emerged as one of the key focal points of China’s
recently concluded 2020 Two Sessions congressional meetings at the
end of May.To get more news about Two Sessions 2020, you can visit shine news official website.
The 2020 Government Work Report delivered by Premier Li Keqiang at the start of the Two Sessions made reference to the need to “actively use foreign capital, greatly reduce the foreign investment negative list and unveil cross-border services and trade negative lists” It also called for “conferring greater independence control over reform and opening to free trade pilot zones, and operating a market environment that treats domestic and foreign invested enterprises independently and provides free competition.” On 25 May Chinese commerce minister Zhong Shan called for “stabilising foreign trade and foreign capital,” including stabilisation of foreign trade, expansion of foreign investment growth, and stabilisation of existing foreign investment.
Zhu Surong , head of the Shenyang branch of the Chinese central bank and representative at the National People’s Congress (NPC), submitted a bill during the Two Sessions which called for “deletion of separate provisions for foreign-invested banks, Sino-foreign joint-venture banks and foreign bank branches,” as well as “further expansion of financial opening and expediting fair market competition.” Xia Jun , managing partner at EY China, said to International Financial News said that opening of domestic markets was a “fundamental state policy” for China.
According to Xia China is encouraging more foreign investment in areas such as advanced manufacturing, emerging industries, tech, clean energy and environmental protection, as its industrial structure shifts from low-value added, energy intensive and pollution intensive sectors to high-value added, low-energy intensity and low-pollution sectors. Xia expects the foreign investment negative list to be greatly reduced, as well as foresees significant simplification of regulatory procedures for foreign invested enterprises. Over the past three years China’s foreign investment negative list has shrunk from 93 items to just 40, while further reductions are expected to take place with a focus on services, manufacturing and agriculture.
The 2020 Government Work Report delivered by Premier Li Keqiang at the start of the Two Sessions made reference to the need to “actively use foreign capital, greatly reduce the foreign investment negative list and unveil cross-border services and trade negative lists” It also called for “conferring greater independence control over reform and opening to free trade pilot zones, and operating a market environment that treats domestic and foreign invested enterprises independently and provides free competition.” On 25 May Chinese commerce minister Zhong Shan called for “stabilising foreign trade and foreign capital,” including stabilisation of foreign trade, expansion of foreign investment growth, and stabilisation of existing foreign investment.
Zhu Surong , head of the Shenyang branch of the Chinese central bank and representative at the National People’s Congress (NPC), submitted a bill during the Two Sessions which called for “deletion of separate provisions for foreign-invested banks, Sino-foreign joint-venture banks and foreign bank branches,” as well as “further expansion of financial opening and expediting fair market competition.” Xia Jun , managing partner at EY China, said to International Financial News said that opening of domestic markets was a “fundamental state policy” for China.
According to Xia China is encouraging more foreign investment in areas such as advanced manufacturing, emerging industries, tech, clean energy and environmental protection, as its industrial structure shifts from low-value added, energy intensive and pollution intensive sectors to high-value added, low-energy intensity and low-pollution sectors. Xia expects the foreign investment negative list to be greatly reduced, as well as foresees significant simplification of regulatory procedures for foreign invested enterprises. Over the past three years China’s foreign investment negative list has shrunk from 93 items to just 40, while further reductions are expected to take place with a focus on services, manufacturing and agriculture.
Could Chloroquine Treat Coronavirus? The following essay is reprinted
with permission from The ConversationThe Conversation, an online
publication covering the latest research.To get more news about chloroquine phosphate, you can visit shine news official website.
An Arizona man died, and his wife was hospitalized, after taking a form of chloroquine, which President Trump has touted as an effective treatment for COVID-19. The couple decided to self-medicate with chloroquine phosphate, which they had on hand to kill parasites in their fish, after hearing the president describe the drug as a “game changer.” Dr. Anthony Fauci, head of NIH’s National Institute for Allergies and Infectious Diseases, quickly corrected the statement, explaining that Trump’s comments were based on anecdotes and not a controlled clinical trial.I am a medicinal chemist who specializes in discovery and development of antiviral drugs, and I have been actively working on coronaviruses for seven years.
However, because I am a scientist and I deal in facts and evidence-based medicine, I am concerned about the sweeping statements the president has been making regarding the use of chloroquine or the closely related hydroxychloroquine, both antimalarial drugs, as cures for COVID-19. So let’s examine the facts.These are both FDA-approved antimalarial drugs that have been in use for many years. Chloroquine was originally developed in 1934 at the pharmaceutical company Bayer and used in World War II to prevent malaria. Although the FDA has not approved its use for these conditions, both chloroquine and hydroxychloroquine are also used to treat rheumatoid arthritis and lupus. After the initial outbreak of MERS in 2012, scientists conducted random screens of thousands of approved drugs to identify one that might block MERS infection.
Several drugs, including chloroquine, showed the ability to block coronaviruses from infecting cells in vitro. But these drugs were not extensively pursued because ultimately they did not show enough activity to be considered further. When the new coronavirus appeared, many drugs that had shown some initial promise against the related coronaviruses MERS and SARS were at the top of the list as worthy of further evaluation as possible treatments.So the science is real, and a number of labs around the world are now investigating these drugs and testing them in clinical trials in the U.S., France and China.
But so far, there is no consensus about whether the drugs are safe and effective for treating COVID-19, as it is still very early in the testing process. It is still unclear how the chloroquines (or any antimalarial drug) would work against COVID-19, which is a virus. Malaria is caused by Plasmodium parasites that are spread by mosquitoes, whereas COVID-19 is caused by the SARS-CoV-2 virus. Viral infections and parasitic infections are very different, and so scientists wouldn’t expect what works for one to work for the other. It has been suggested that the chloroquines can change the acidity at the surface of the cell, thereby preventing the virus from infecting it. It’s also possible chloroquines help activate the immune response. One study that was just published tested hydroxychloroquine in combination with an antibacterial drug (azithromycin), which worked better to stop the spread of the infection than hydroxychloroquine alone. However it’s only one preliminary study that was done on a limited test group.
An Arizona man died, and his wife was hospitalized, after taking a form of chloroquine, which President Trump has touted as an effective treatment for COVID-19. The couple decided to self-medicate with chloroquine phosphate, which they had on hand to kill parasites in their fish, after hearing the president describe the drug as a “game changer.” Dr. Anthony Fauci, head of NIH’s National Institute for Allergies and Infectious Diseases, quickly corrected the statement, explaining that Trump’s comments were based on anecdotes and not a controlled clinical trial.I am a medicinal chemist who specializes in discovery and development of antiviral drugs, and I have been actively working on coronaviruses for seven years.
However, because I am a scientist and I deal in facts and evidence-based medicine, I am concerned about the sweeping statements the president has been making regarding the use of chloroquine or the closely related hydroxychloroquine, both antimalarial drugs, as cures for COVID-19. So let’s examine the facts.These are both FDA-approved antimalarial drugs that have been in use for many years. Chloroquine was originally developed in 1934 at the pharmaceutical company Bayer and used in World War II to prevent malaria. Although the FDA has not approved its use for these conditions, both chloroquine and hydroxychloroquine are also used to treat rheumatoid arthritis and lupus. After the initial outbreak of MERS in 2012, scientists conducted random screens of thousands of approved drugs to identify one that might block MERS infection.
Several drugs, including chloroquine, showed the ability to block coronaviruses from infecting cells in vitro. But these drugs were not extensively pursued because ultimately they did not show enough activity to be considered further. When the new coronavirus appeared, many drugs that had shown some initial promise against the related coronaviruses MERS and SARS were at the top of the list as worthy of further evaluation as possible treatments.So the science is real, and a number of labs around the world are now investigating these drugs and testing them in clinical trials in the U.S., France and China.
But so far, there is no consensus about whether the drugs are safe and effective for treating COVID-19, as it is still very early in the testing process. It is still unclear how the chloroquines (or any antimalarial drug) would work against COVID-19, which is a virus. Malaria is caused by Plasmodium parasites that are spread by mosquitoes, whereas COVID-19 is caused by the SARS-CoV-2 virus. Viral infections and parasitic infections are very different, and so scientists wouldn’t expect what works for one to work for the other. It has been suggested that the chloroquines can change the acidity at the surface of the cell, thereby preventing the virus from infecting it. It’s also possible chloroquines help activate the immune response. One study that was just published tested hydroxychloroquine in combination with an antibacterial drug (azithromycin), which worked better to stop the spread of the infection than hydroxychloroquine alone. However it’s only one preliminary study that was done on a limited test group.
